M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 4.48 EUR 8.74% Market Closed
Market Cap: 84m EUR

Intrinsic Value

The intrinsic value of one MAAT stock under the Base Case scenario is 11.74 EUR. Compared to the current market price of 4.48 EUR, Maat Pharma SA is Undervalued by 62%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MAAT Intrinsic Value
11.74 EUR
Undervaluation 62%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Maat Pharma SA

What is Valuation History?
Ask AI Assistant
What other research platforms think about MAAT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MAAT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Maat Pharma SA.

Explain Valuation
Compare MAAT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MAAT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Maat Pharma SA

Current Assets 36m
Cash & Short-Term Investments 15.1m
Receivables 19m
Other Current Assets 1.9m
Non-Current Assets 13m
Long-Term Investments 200k
PP&E 7.9m
Intangibles 2.9m
Other Non-Current Assets 2m
Current Liabilities 16m
Accounts Payable 10m
Accrued Liabilities 2.6m
Other Current Liabilities 3.4m
Non-Current Liabilities 25m
Long-Term Debt 12m
Other Non-Current Liabilities 13m
Efficiency

Free Cash Flow Analysis
Maat Pharma SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Maat Pharma SA

Revenue
3.9m EUR
Cost of Revenue
-1.5m EUR
Gross Profit
2.4m EUR
Operating Expenses
-33.4m EUR
Operating Income
-31m EUR
Other Expenses
0 EUR
Net Income
-31m EUR
Fundamental Scores

MAAT Profitability Score
Profitability Due Diligence

Maat Pharma SA's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
24/100
Profitability
Score

Maat Pharma SA's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

MAAT Solvency Score
Solvency Due Diligence

Maat Pharma SA's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
32/100
Solvency
Score

Maat Pharma SA's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Wall Street analysts forecast MAAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAAT is 17.12 EUR with a low forecast of 13.13 EUR and a high forecast of 22.05 EUR.

Lowest
Price Target
13.13 EUR
193% Upside
Average
Price Target
17.12 EUR
282% Upside
Highest
Price Target
22.05 EUR
392% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Maat Pharma SA
does not pay dividends
Shareholder Yield

Current shareholder yield for MAAT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MAAT stock?

The intrinsic value of one MAAT stock under the Base Case scenario is 11.74 EUR.

Is MAAT stock undervalued or overvalued?

Compared to the current market price of 4.48 EUR, Maat Pharma SA is Undervalued by 62%.

Back to Top